96 related articles for article (PubMed ID: 6624683)
1. Fatty acylcarnitine accumulation and membrane injury in ischemic canine myocardium.
Chien KR; Sen A; Buja LM; Willerson JT
Am J Cardiol; 1983 Oct; 52(7):893-7. PubMed ID: 6624683
[TBL] [Abstract][Full Text] [Related]
2. On the possible role of long chain fatty acylcarnitine accumulation in producing functional and calcium permeability changes in membranes during myocardial ischaemia.
Lamers JM; De Jonge-Stinis JT; Verdouw PD; Hülsmann WC
Cardiovasc Res; 1987 May; 21(5):313-22. PubMed ID: 3652098
[TBL] [Abstract][Full Text] [Related]
3. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart.
DaTorre SD; Creer MH; Pogwizd SM; Corr PB
J Mol Cell Cardiol; 1991 Feb; 23 Suppl 1():11-22. PubMed ID: 2038071
[TBL] [Abstract][Full Text] [Related]
4. Effects of L-carnitine on tissue levels of free fatty acid, acyl CoA, and acylcarnitine in ischemic heart.
Suzuki Y; Kamikawa T; Kobayashi A; Yamazaki N
Adv Myocardiol; 1983; 4():549-57. PubMed ID: 6856980
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of unesterified arachidonic acid in ischemic canine myocardium. Relationship to a phosphatidylcholine deacylation-reacylation cycle and the depletion of membrane phospholipids.
Chien KR; Han A; Sen A; Buja LM; Willerson JT
Circ Res; 1984 Mar; 54(3):313-22. PubMed ID: 6421507
[TBL] [Abstract][Full Text] [Related]
6. 1H NMR measurement of triacylglycerol accumulation in the post-ischemic canine heart after transient increase of plasma lipids.
Balschi JA; Hai JO; Wolkowicz PE; Straeter-Knowlen I; Evanochko WT; Caulfield JB; Bradley E; Ku DD; Pohost GM
J Mol Cell Cardiol; 1997 Feb; 29(2):471-80. PubMed ID: 9140807
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of unsaturated acylcarnitine molecular species during acute myocardial ischemia: metabolic compartmentalization of products of fatty acyl chain elongation in the acylcarnitine pool.
Ford DA; Han X; Horner CC; Gross RW
Biochemistry; 1996 Jun; 35(24):7903-9. PubMed ID: 8672492
[TBL] [Abstract][Full Text] [Related]
8. Histochemical, ultrastructural and cytochemical study of reperfusion effect on ischemic myocardial injury.
Fukuhara T
Jpn Circ J; 1985 Apr; 49(4):432-45. PubMed ID: 3159916
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural damage and Ca2(+)-shifts in the canine myocardium subjected to regional incomplete ischemia.
Vandeplassche G; Thoné F; Hermans C; Borgers M
Basic Res Cardiol; 1990; 85(4):384-91. PubMed ID: 2241768
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid alterations in canine ischemic myocardium. Temporal and topographical correlations with Tc-99m-PPi accumulation and an in vitro sarcolemmal Ca2+ permeability defect.
Chien KR; Reeves JP; Buja LM; Bonte F; Parkey RW; Willerson JT
Circ Res; 1981 May; 48(5):711-9. PubMed ID: 7214679
[No Abstract] [Full Text] [Related]
11. Effects of glucose-insulin-potassium solution on free fatty acid metabolism in ischemic myocardium.
Kobayashi A; Kamiya J; Yamashita T; Ishizaka K; Hayashi H; Kamikawa T; Yamazaki N
Jpn Circ J; 1984 Jun; 48(6):591-5. PubMed ID: 6376844
[TBL] [Abstract][Full Text] [Related]
12. Effect of L-carnitine on the cellular distribution of carnitine and its acyl derivatives in the ischemic heart.
Fujisawa S; Kobayashi A; Hironaka Y; Yamazaki N
Jpn Heart J; 1992 Sep; 33(5):693-705. PubMed ID: 1289599
[TBL] [Abstract][Full Text] [Related]
13. Reversible, highly localized alterations in fatty acid metabolism in the chronically ischemic canine myocardium.
Kang ES; Mirvis DM
Am J Cardiol; 1984 Aug; 54(3):411-4. PubMed ID: 6465025
[TBL] [Abstract][Full Text] [Related]
14. Ischemia-induced alterations in myocardial (Na+ + K+)-ATPase and cardiac glycoside binding.
Beller GA; Conroy J; Smith TW
J Clin Invest; 1976 Feb; 57(2):341-50. PubMed ID: 130383
[TBL] [Abstract][Full Text] [Related]
15. Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion.
Buxton DB; Mody FV; Krivokapich J; Schelbert HR
J Mol Cell Cardiol; 1993 Jun; 25(6):667-81. PubMed ID: 8411193
[TBL] [Abstract][Full Text] [Related]
16. Redistribution of catecholamines in the ischemic zone of the dog heart.
Muntz KH; Hagler HK; Boulas HJ; Willerson JT; Buja LM
Am J Pathol; 1984 Jan; 114(1):64-78. PubMed ID: 6691416
[TBL] [Abstract][Full Text] [Related]
17. Evidence that ischemic cell death begins in the subendocardium independent of variations in collateral flow or wall tension.
Lowe JE; Cummings RG; Adams DH; Hull-Ryde EA
Circulation; 1983 Jul; 68(1):190-202. PubMed ID: 6851046
[TBL] [Abstract][Full Text] [Related]
18. Effects of procainamide and disopyramide on long chain acyl carnitine and long chain acyl CoA concentrations in the ischemic heart.
Kobayashi A; Watanabe H; Yamazaki N
Jpn Heart J; 1988 Nov; 29(6):831-40. PubMed ID: 3241336
[TBL] [Abstract][Full Text] [Related]
19. A nonflow basis for the vulnerability of the subendocardium.
Eng C; Cho S; Factor SM; Kirk ES
J Am Coll Cardiol; 1987 Feb; 9(2):374-9. PubMed ID: 3805528
[TBL] [Abstract][Full Text] [Related]
20. Spatial distribution of [14C]-lidocaine and blood flow in transmural and lateral border zones of ischemic canine myocardium.
Patterson RE; Weintraub WS; Halgash DA; Miao J; Rogers JR; Kupersmith J
Am J Cardiol; 1982 Jul; 50(1):63-73. PubMed ID: 7091007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]